Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Anand Grover

Elgar Parishad case: SC Justice S Chandrashekhar recuses from hearing Gadling's bail plea

Justice Shree Chandrashekhar recused himself from hearing advocate Surendra Gadling's bail plea. This marks the third judge to recuse from the Elgar Parishad case matter. Gadling has been incarcerated for over seven years, seeking an urgent hearing. His bail plea has faced multiple adjournments in the Supreme Court. Gadling faces…

The Economic Times

Elgar Parishad case: SC agrees to hear next week advocate Surendra Gadling's bail plea

Elgar Parishad case: SC agrees to hear next week advocate Surendra Gadling's bail plea

The Supreme Court will hear advocate Surendra Gadling's bail plea next week. Gadling has been jailed for seven-and-a-half years in the Elgar Parishad case. His bail plea has been adjourned eleven times previously in the Supreme Court. The case involves alleged Maoist links and provocative speeches delivered at a conclave.…

The Economic Times

Supreme Court refuses to re-examine bail granted to accused in Dabholkar murder case

Supreme Court refuses to re-examine bail granted to accused in Dabholkar murder case

The Supreme Court dismissed a challenge to bail granted by the Bombay High Court to an accused in the murder of rationalist Narendra Dabholkar in 2013

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Draft patent amendment rules undermine pre-grant opposition

Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends…

Four Imphal-based lawyers withdraw from Kuki Professor’s case after Meitei threat

Lawyers in Imphal withdraw from case of Hyderabad Univ. Prof. Kham Khan Suan Hausing after threats from Meitei community. SC had issued interim order protecting him. Advocates faced threats & vandalism, so withdrew. Indigenous Tribal Leaders' Forum condemns incident, citing intolerance & radicalisation.

Trial court can decide Varavara Rao’s plea to visit Hyderabad for surgery: SC

Mr. Rao’s bail conditions do not permit travel out of Greater Mumbai

Bengal post-poll violence: SC grants four weeks to Centre, State to file reply

The top court was hearing a plea, filed by UP-based lawyer Ranjana Agnihotri and social worker Jitender Singh, seeking direction from the Centre to impose President’s Rule in Bengal

inkl

Read news from The Economist, FT, and more,
with one subscription

Bhima Koregaon case | SC to take up Varavara Rao’s plea for permanent bail on Tuesday

Bhima Koregaon case | SC to take up Varavara Rao’s plea for permanent bail on Tuesday

A Bench led by Justice U.U. Lalit could not take up the case, which was listed as item number 30 on Monday, as the judges had to sit in a different combination at 2 p.m.

Hyderpora encounter: Supreme Court asks Jammu Kashmir High Court to hear plea of man seeking exhumation of son’s body

Hyderpora encounter: Supreme Court asks Jammu Kashmir High Court to hear plea of man seeking exhumation of son’s body

New Delhi The Supreme Court Monday asked the Jammu and Kashmir High Court to consider either on Tues

‘Seriousness’ of Elgar Parishad case remains: Bombay High Court

‘Seriousness’ of Elgar Parishad case remains: Bombay High Court

Bombay High Court rejects Varavara Rao’s plea for permanent medical bail

Bombay High Court dismisses Varavara Rao’s plea for permanent bail

Bombay High Court dismisses Varavara Rao’s plea for permanent bail

Court, however, extends temporary medical bail by three months

The Bedaquiline Question

The Bedaquiline Question

One of the increasingly contentious public health issues in India is the manner in which clinical trials are conducted for new drugs and the manner in which these new drugs are subsequently approved for use on Indian patients.

1

People

Prashant Kumar Mishra

Ranjana Agnihotri

Narendra Dabholkar

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bharatiya Janata Party

the Supreme Court

the Bombay High Court

Bombay High Court

the Manipur High Court

Jammu and Kashmir High Court

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Jammu and Kashmir

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play